Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Diabetes, Obesity & Metabolism|December 23, 2017
Non-severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: Results from the Diabetes Control and Complication TrialAnisoara Bumbu, Abdul Moutairou, Odette Matar, et al.
Cardiovascular Diabetology|August 24, 2013
Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjectsPedro Saddi-Rosa, Carolina Oliveira, Felipe Crispim, et al.
Diabetes Care|December 22, 2016
Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective CohortPierre-Jean Saulnier, Elise Gand, Gilberto Velho, et al.
Cardiovascular Diabetology|November 18, 2022
Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC populationIulia Petria, Samuel Albuquerque, Gaël Varoquaux, et al.
The Journal of Clinical Endocrinology and Metabolism|April 7, 2016
Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the CommunityRonan Roussel, Ray El Boustany, Nadine Bouby, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2014
Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney diseaseRonan Roussel, Léopold Fezeu, Michel Marre, et al.
Diabetologia|February 28, 2019
Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic useLouis Potier, Ronan Roussel, Gilberto Velho, et al.
Diabetes Care|October 13, 2016
Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 DiabetesGilberto Velho, Ray El Boustany, Guillaume Lefèvre, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|January 27, 2009
HNF1alpha mutations are present in half of clinically defined MODY patients in South-Brazilian individualsJorge de Faria Maraschin, Caroline Kannengiesser, Nádia Murussi, et al.
American Journal of Nephrology|September 9, 2015
Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. StudyRonan Roussel, Nadia Matallah, Nadine Bouby, et al.
Pageof 9